BioCentury | Feb 20, 2012
Clinical News

GeneChip System 3000Dx v regulatory update

...Origin Test from Pathwork Diagnostics Inc. (Redwood City, Calif.) and acute myelogenous leukemia (AML) diagnostic AMLprofiler...
BioCentury | Sep 12, 2011
Company News

Clavis, Skyline Diagnostics deal

...Details were not disclosed. Skyline, which develops array-based diagnostics that individualize patient treatment, markets its AMLprofiler...
BioCentury | Mar 21, 2011
Clinical News

AMLprofiler regulatory update

...Skyline received CE mark approval in the EU for its AMLprofiler microarray in vitro diagnostic for...
...from TrovaGene Inc. (Pink:TROV, San Diego, Calif.). Skyline Diagnostics B.V. , Rotterdam, the Netherlands Product: AMLprofiler...
BioCentury | Jul 5, 2010
Company News

Skyline Diagnostics, Trovagene deal

...Skyline received a license to use TrovaGene's nucleophosmin ( NPM1 ; B23) technology in Skyline's AMLprofiler...
...prognosis, the presence of minimal residual disease and early recurrence. Skyline plans to offer the AMLprofiler...
Items per page:
1 - 4 of 4